USRC Tonawanda 10/2009-present

USRC West Cheektowaga, LLC 05/2016-present

Dr. Imad Ahmed is the proposed Medical Director. He is currently employed at Nephrology Associates of
WNY for over two (2) years. He was previously employed at the Renal Associates of West Michigan for
over nine (9) years. He is a practicing Nephrologist with over 10 years of experience. He is board-certified
in Internal Medicine with a sub-specialty in Nephrology. He completed his Internal Medicine residency at
State University of New York Upstate Medical Center. He completed his fellowship in Nephrology at
University of Rochester. He recently (2018) relocated from Michigan to New York to be closer to his family
but was previously Medical Director of two dialysis facilities in Michigan.

Dr. Namassivaya Arundathi is a practicing Nephrologist for over 18 years. He received his medical
degree from Maine Medical Center. He completed his Nephrology fellowship at Maine Medical Center. Dr.
Arundathi discloses ownership interest in the following health care facilities:
USRC Williamsville 10/2009-present
USRC Cheektowaga 10/2009-present
USRC Tonawanda 10/2009-present
USRC West Cheektowaga, LLC 05/2016-present
USRC Amherst 07/2018-present

Dr. Maria Del Castillo is a practicing Nephrologist and partner at Nephrology Associates of WNY with
over 24 years of experience. She is board-certified in Nephrology. She has experience in the
management of patients with end stage renal disease as well as all stages of primary and chronic kidney
disease and acute kidney complications. Dr. Del Castillo discloses ownership interest in the following
healthcare facilities:
USRC Tonawanda 10/2011-present
USRC Cheektowaga 10/2011-present
USRC Williamsville 10/2011-present
USRC West Cheektowaga, LLC 11/2016-present
USRC Amherst, LLC 07/2018-present

Dr. Kristin Matteson is a practicing Nephrologist and managing partner in Nephrology Associates of
WNY, LLC for 17 years. Her duties include diagnosis and managing nephrology patients including end
stage renal disease and dialysis. As a partner she has experience with human resources and financial
statements. Dr. Matteson discloses ownership interest in the following healthcare facilities:
USRC Tonawanda 11/2011-present
USRC Cheektowaga 11/2011-present
USRC Williamsville 11/2011-present
USRC West Cheektowaga, LLC 10/2017-present
USRC Amherst, LLC 07/2018-present

Dr. Richard Steinacher is a practicing Nephrologist and a partner in Nephrology Associates of WNY, a
busy, nine physician nephrology practice in the Buffalo area. He provides both inpatient and outpatient
nephrology care at four local hospitals. He is currently the Medical Director of USRC Amherst Dialysis. Dr.
Steinacher discloses ownership interest in the following healthcare facilities:
USRC West Cheektowaga 05/2016-present
USRC Amherst Dialysis 07/2018-present

Dr. Heather Wheat is a practicing Nephrologist with over 12 years of experience. She is the Medical
Director of Nephrology Associates of WNY. She has extensive experience in inpatient and outpatient
nephrology as well as taking care of dialysis patients. Dr. Wheat discloses ownership interest in the
following healthcare facilities:
USRC Tonawanda 10/2009-present
USRC Cheektowaga 10/2009-present
USRC Williamsville 10/2009-present
USRC West Cheektowaga, LLC 05/2016-present
USRC Amherst 07/2018-present
Project #192048-B Exhibit Page 8
Staff from the Division of Certification & Surveillance reviewed the disclosure information submitted
regarding licenses held, formal education, training in pertinent health and/or related areas, employment
history, a record of legal actions, and a disclosure of the applicant’s ownership interest in other health
care facilities. Licensed individuals were checked against the Office of Medicaid Management, the Office
of Professional Medical Conduct, and the Education Department databases as well as the US
Department of Health and Human Services Office of the Inspector General Medicare exclusion database.

Messrs., Shelton, and Weinberg disclosed in February 2010, an investigation from the Office of the
Inspector General of the U.S. Department of Health and Human Services (OIG) related to alleged
improper Medicare and Medicaid billing at certain Dialysis Corporation of America (DCA) clinics. In
February 2010, prior to the USRC’s acquisition of DCA, DCA received a subpoena from the Office of the
Inspector General of the U.S. Department of Health and Human Services (OIG) with respect to an
investigation relating to improper Medicare and Medicaid billing at certain DCA clinics. DCA fully
cooperated with the inquiry. The investigation related to two (2) qui tam suits with the Department of
Justice and private litigants. U.S. Renal Care, Inc acquired DCA in June 2010. United States ex. rel
Davis v. Dialysis Corporation of America, Inc., Case No. 1:08-cv-02829 (D. Md); and United States ex. rel.
Harris, et al. v. DCA, Case No. 1: 09-cv-02457-JKB (D. Md). The U.S. government intervened in the Davis
case but declined to intervene in the Harris case. USRC denied any impropriety or liability by DCA in both
cases but determined that it should settle these cases with the U.S. government and the private litigants.
The two suits filed by the U.S. government were settled, the Davis case on May 17, 2013 and the Harris
case September 12, 2014. No non-DCA facilities owned by U.S. Renal Care were involved in the above-
referenced investigations and litigation.

Dr. Matteson disclosed that she as named in a malpractice case filed in 2016. The suit was brought in
connection with care and treatment during the hospitalization from November 12 to November 17, 2013.
The patient was post-op from rectal surgery requiring a temporary ileostomy and ultimately passed away.
Dr. Matteson was the patient’s consulting nephrologist. The case was voluntarily discontinued in
November 2017.

Additionally, the staff from the Division of Certification & Surveillance reviewed the ten-year surveillance
history of all associated facilities. Sources of information included the files, records, and reports found in
the Department of Health. Included in the review were the results of any incident and/or complaint
investigations, independent professional reviews, and/or comprehensive/focused inspections. The review
found that any citations were properly corrected with appropriate remedial action.

The Department has taken the following enforcement action against U.S. Renal Care, Inc affiliated
facilities:
 On April 7, 2017, the Department issued a Stipulation and Order (S&O) and $2,000 fine for
surveillance findings of December 9, 2016 related to Construction prior to Department of Health
approval. Specifically, the operator started construction on this new ESRD facility prior to
receiving an all contingencies satisfied letter and approval to begin construction from the
Department.
 The Department of Health and Welfare in Idaho and CMS initiated a 90-day termination track for
Liberty Dialysis Idaho Falls, LLC on September 01, 2011 due to no-compliance with the
Conditions for Coverage-Patient Care Plan and Responsibilities of the Medical Director.
 The Department of Health and Welfare in Idaho and CMS initiated a 90-day termination track for
Liberty Dialysis-Nampa LLC on February 11, 2011 due to no-compliance with Conditions for
Coverage-Patient Care Plan and QAPI.
 The Department of Health of South Carolina declared Immediate Jeopardy on September 14,
2012 at NRA Orangeburg South Carolina LLC d/b/a Orangeburg Dialysis Clinic related to
Infection Control. The Immediate Jeopardy was removed on later on September 14, 2012 @ 10
am. The conditions were corrected on a later revisit.

Project #192048-B Exhibit Page 9